Rep. Jake Auchincloss, currently serving in the U.S. Congress representing Massachusetts’ 4th district, shared several updates on November 26, 2024, through his official social media account. The tweets highlight his presence on a new platform and legislative efforts concerning pharmaceutical regulations.
In a tweet posted at 21:12 UTC, Rep. Auchincloss announced his official presence on Bluesky with the handle “@repauchincloss.bsky.social.” He stated, “Catch me on Bluesky – my sole official account is @repauchincloss.bsky.social.”
Later that day at 22:06 UTC, he emphasized the importance of accurate reporting for drug reimbursement processes by stating that Congress must codify mandatory NADAC reporting as a basis for reimbursement. He asserted, “This is why mandatory & accurate NADAC reporting must be codified by Congress as the basis for reimbursement.”
At 22:56 UTC, Rep. Auchincloss celebrated a milestone for the #PharmacistsFightBackAct, which achieved its goal of securing 50 co-sponsors by Thanksgiving. He attributed this success to pharmacists and advocates fighting against PBM greed and remarked that Congress cannot ignore these voices. His tweet read, “The goal was 50 co-sponsors by Thanksgiving. #PharmacistsFightBackAct now has 50! This momentum was made possible by the pharmacists, advocates, and patients who have rallied to end PBM greed. Congress can’t ignore these powerful voices.”
